EP1281 Total parietal peritonectomy: what morbidity? and which sites of recurrence?
Introduction/BackgroundTo evaluate the morbidity of perioperative total parietal peritonectomy (TPP) during cytoreduction surgery (CRS), and its impact on the site of recurrence of different peritoneal surface malignancies (PSM).MethodologyWe led a retrospective study in a French tertiary cancer ins...
Saved in:
| Published in: | International journal of gynecological cancer Vol. 29; no. Suppl 4; p. A646 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Kidlington
Elsevier Inc
01.11.2019
Elsevier Limited |
| Subjects: | |
| ISSN: | 1048-891X, 1525-1438 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Introduction/BackgroundTo evaluate the morbidity of perioperative total parietal peritonectomy (TPP) during cytoreduction surgery (CRS), and its impact on the site of recurrence of different peritoneal surface malignancies (PSM).MethodologyWe led a retrospective study in a French tertiary cancer institution (Centre Oscar Lambret - Lille) experienced in treating PSM over a 6-year period from 2012 to 2018. All patients underwent a total parietal peritonectomy during a debulking surgery for PSM including ovarian cancer, appendiceal pseudomyxoma peritonei or peritoneal mesothelioma.ResultsSixty-one patients were included in this study with 79% of them having ovarian cancer. The rate of optimal surgery reached 87% with almost 70% of surgeries being highly complicated. 74.2% were transfused during the surgical procedure. The median hospitalization stay was 10 days including 7 days in Intensive Care Unit (ICU). 30% had early postoperative complications with no grade 4 and 42% Grade 3 complications. After a 30-months median follow-up, 84% of ovarian cancer group had no recurrence of the disease the first year and a 3-year survival of 77%. The main site of first and second recurrence was peritoneal (51% and 56.3%). In this series, there have been no cases of metastatic evolution of the abdominal wall.ConclusionTPP is a feasible surgical procedure to treat peritoneal surface malignancies and their recurrences with a low rate of Grade 3–4 morbidity. Even though, TPP doesn’t prevent peritoneal recurrence, it allow optimal surgery.DisclosureNothing to disclose |
|---|---|
| AbstractList | Introduction/BackgroundTo evaluate the morbidity of perioperative total parietal peritonectomy (TPP) during cytoreduction surgery (CRS), and its impact on the site of recurrence of different peritoneal surface malignancies (PSM).MethodologyWe led a retrospective study in a French tertiary cancer institution (Centre Oscar Lambret - Lille) experienced in treating PSM over a 6-year period from 2012 to 2018. All patients underwent a total parietal peritonectomy during a debulking surgery for PSM including ovarian cancer, appendiceal pseudomyxoma peritonei or peritoneal mesothelioma.ResultsSixty-one patients were included in this study with 79% of them having ovarian cancer. The rate of optimal surgery reached 87% with almost 70% of surgeries being highly complicated. 74.2% were transfused during the surgical procedure. The median hospitalization stay was 10 days including 7 days in Intensive Care Unit (ICU). 30% had early postoperative complications with no grade 4 and 42% Grade 3 complications. After a 30-months median follow-up, 84% of ovarian cancer group had no recurrence of the disease the first year and a 3-year survival of 77%. The main site of first and second recurrence was peritoneal (51% and 56.3%). In this series, there have been no cases of metastatic evolution of the abdominal wall.ConclusionTPP is a feasible surgical procedure to treat peritoneal surface malignancies and their recurrences with a low rate of Grade 3–4 morbidity. Even though, TPP doesn’t prevent peritoneal recurrence, it allow optimal surgery.DisclosureNothing to disclose |
| Author | Le Deley, MC Saadeh, R Hudry, D Narducci, F Leblanc, E Berthet, A |
| Author_xml | – sequence: 1 givenname: D surname: Hudry fullname: Hudry, D organization: Université de Lille, Lille, France – sequence: 2 givenname: A surname: Berthet fullname: Berthet, A organization: Université de Lille, Lille, France – sequence: 3 givenname: R surname: Saadeh fullname: Saadeh, R organization: Université de Lille, Lille, France – sequence: 4 givenname: MC surname: Le Deley fullname: Le Deley, MC organization: Université de Lille, Lille, France – sequence: 5 givenname: F surname: Narducci fullname: Narducci, F organization: Université de Lille, Lille, France – sequence: 6 givenname: E surname: Leblanc fullname: Leblanc, E organization: Université de Lille, Lille, France |
| BookMark | eNp9kM1KAzEUhYNUsK0-gZsB11OTzF8iSJFSq1CoYAvuQia5sRnaSc1Mle7c-KI-iRnr2tU9XM659_ANUK92NSB0SfCIkCS_ttWriikmPJ4-zxYjQllxgvoko1lM0oT1gsYpixknL2do0DQVxphTzPtoNX0KbvL9-bV0rdxEO-kt_Arwtg1fVOu2h5voYy3baOt8abVtD-NI1jrsrFpHjW2hiZyJPKi991ArGJ-jUyM3DVz8zSFa3U-Xk4d4vpg9Tu7mcUloKMsopDyHElOmoZTU6ITqUhbYKG0wEJYkOi8wzTWXplBZhlNiEi61NlqXoJMhujre3Xn3toemFZXb-zq8FDTLKGMkz3hw3R5dEKq8W_CiUbbrqW3o3ArtrCBYdCRFR1J0JEVHUnQkQ350zJfbSuy83Up_-DfwA86Qeus |
| ContentType | Journal Article |
| Copyright | Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. 2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. |
| Copyright_xml | – notice: Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. |
| DBID | 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS |
| DOI | 10.1136/ijgc-2019-ESGO.1287 |
| DatabaseName | ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Proquest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China |
| DatabaseTitle | ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest One Health & Nursing ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest One Academic ProQuest Central (New) ProQuest Central (Alumni) ProQuest One Academic (New) |
| DatabaseTitleList | ProQuest One Academic Middle East (New) |
| Database_xml | – sequence: 1 dbid: 7X7 name: Health & Medical Collection (Proquest) url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1525-1438 |
| EndPage | A646 |
| ExternalDocumentID | S1048891X24142557 ijgc |
| GroupedDBID | --- .3N .Z2 0R~ 1OC 29J 31~ 36B 4.4 53G 5GY 5VS 7X7 8-1 8FI 8FJ AAHLL AAKAS AARTV AAXUO ABBUW ABJNI ABUWG ABXVJ ABZAD ACDDN ACEWG ACGFO ACGFS ACWDW ACWRI ACXNZ ACXQS ADZCM AENEX AFBPY AFEBI AFKRA AFTRI AFZJQ AGINI AHEFC AIZYK AJAOE AJNYG AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS BENPR BFHJK BQLVK CAG CCPQU CO8 COF CS3 CXRWF DC6 DCZOG E.X EBS EJD EX3 F5P FDB FL- FYUFA FZ0 HAJ HMCUK HZI HZ~ IHE IN~ KD2 L-C LH4 LW6 M41 O9- OCUKA OHYEH ORVUJ OUVQU OVD OXXIT P2P RMJ ROL S4S TEORI UDS UKHRP V2I W3M W99 WOW X3V X3W YUY AWKKM 3V. 7XB 8FK AALRI AAYWO ACVFH ADCNI AEUPX AFPUW AIGII AKBMS AKYEP AMRAJ K9. PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS |
| ID | FETCH-LOGICAL-b1219-82e496eb028deba2fd32dba70fcdf0e1833d67026d9af7c55041f39addfddbed3 |
| IEDL.DBID | BENPR |
| ISSN | 1048-891X |
| IngestDate | Tue Oct 07 07:13:31 EDT 2025 Sat Dec 28 15:51:36 EST 2024 Fri Apr 25 03:17:35 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | Suppl 4 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b1219-82e496eb028deba2fd32dba70fcdf0e1833d67026d9af7c55041f39addfddbed3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
| PQID | 2552881659 |
| PQPubID | 5161120 |
| ParticipantIDs | proquest_journals_2552881659 elsevier_sciencedirect_doi_10_1136_ijgc_2019_ESGO_1287 bmj_primary_10_1136_ijgc_2019_ESGO_1287 |
| PublicationCentury | 2000 |
| PublicationDate | 20191100 November 2019 20191101 |
| PublicationDateYYYYMMDD | 2019-11-01 |
| PublicationDate_xml | – month: 11 year: 2019 text: 20191100 |
| PublicationDecade | 2010 |
| PublicationPlace | Kidlington |
| PublicationPlace_xml | – name: Kidlington |
| PublicationTitle | International journal of gynecological cancer |
| PublicationYear | 2019 |
| Publisher | Elsevier Inc Elsevier Limited |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier Limited |
| SSID | ssj0009209 |
| Score | 2.234771 |
| Snippet | Introduction/BackgroundTo evaluate the morbidity of perioperative total parietal peritonectomy (TPP) during cytoreduction surgery (CRS), and its impact on the... |
| SourceID | proquest elsevier bmj |
| SourceType | Aggregation Database Publisher |
| StartPage | A646 |
| SubjectTerms | Gastric cancer Morbidity Ovarian cancer Surgery |
| Title | EP1281 Total parietal peritonectomy: what morbidity? and which sites of recurrence? |
| URI | https://ijgc.bmj.com/content/29/Suppl_4/A646.1.full https://dx.doi.org/10.1136/ijgc-2019-ESGO.1287 https://www.proquest.com/docview/2552881659 |
| Volume | 29 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection (Proquest) customDbUrl: eissn: 1525-1438 dateEnd: 20241231 omitProxy: false ssIdentifier: ssj0009209 issn: 1048-891X databaseCode: 7X7 dateStart: 20180101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1525-1438 dateEnd: 20241231 omitProxy: false ssIdentifier: ssj0009209 issn: 1048-891X databaseCode: BENPR dateStart: 20180101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwED5BQYiFN6K85AGJKdDUqROzVIAKLJQKitTNil-0ldqUtoDYWPij_BLOqSsEQxe2KJETK9_n7-78uAM44kryKMWBxIzmQWSRxklZ0oDahGmFpIq4zYtNxPV60mrxhp9wG_ltlVNNzIVaZ8rNkZ-i61tOkpBVeHXwHLiqUW511ZfQmIcFl6ksKsDCRa3euP9JuzvZ5IExRxIkPGz5vEMhZaed7pNCjoQ8qD1c352gTjsLJXvdX2bpj0DnVudq9b_9XYMV72-S8wlB1mHO9Ddg6davqG_CY63hVrm-Pj6bGfrhxBUlNPkFUtMl6lbjrPd-Rt7a6Zj0sqHsaPTbqyTta7zXUW3iPjgimSVDN3WfHx6sbsHjVa15eRP4UguBDFGzEB8TcWYkehvayLRsNS1rmcYlq7QtGRz3VLMY4zXNUxsrDGui0FKO4mi1lkbTbSj0sU87QKyOsQXKAktdntKSZKaEb08Up5XU0qgIx_iTxWCSTEPkQQhlwsEhHBzCwSEcHEVgUyCE9wcmdl6g3M9uuD_FRPghORI_gOzOfrwHyzkt8gOH-1AYD1_MASyq13FnNDyE-bgVH3qefQMatdrm |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9wwEB4BRcCF8mjFs_jQilPYTRycGAmtKro8BCxILNLeTPyCRdoN7G6LuHHh7_RH9Zd07CRC5cCNQ29RIjt2vs_ziMczAF-5kjzOcCExo3kQW6RxGkkaUJsyrZBUMbe-2ETSaqWdDj8fg9_VWRgXVlnJRC-oda7cP_Iamr5RmoZsmzfu7gNXNcrtrlYlNApaHJvHB3TZhrtHPxDfb1G032zvHQZlVYFAhrg8cSgm5sxIVKzayCyymkZaZkndKm3rBilONUvQNdE8s4lCCz4OLeUoB6zW0miK_Y7DB5TjiQshSzrJS5LfIqQEPZw0SHnYKbMchZTVurfXChmJ729eHJxtoVZw-lD2bv9Rgq_Ugddx-x__t68zB7OlNU2-F_SfhzHTX4Cp0zJeYBEum-duD-_P03M7Ry-DuJKLxl_gwnNpyNUo7z3ukIebbER6-UB2NXolDZL1Nd7rqhviJjgkuSUDtzHhj0Y2PsHlu0zqM0z0cUxLQKxOsAUKPZa5LKx1yUwde08Vp9uZpfEybCKo4q5IFSK8i0WZcPALB79w8AsH_zKwCnhRWjuFFSNQmb3dcK3igCgFzlC8EGDl7ccbMH3YPj0RJ0et41WY8ZT0RyvXYGI0-GnWYVL9GnWHgy-e2wSu3psufwElazjw |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1Z1JT9tAFICfaECICwVKxc4cWnEyiT3O2INURSwJRZQ0YpFym3o2CFJiSAKIWy_9U_wcfglvvAi1B24cerNszWjs-eYtnjfvAXzhSvIwwYXEjOZeaBHjOJDUozZmWiFUIbdZsYmo3Y67Xd6ZgKfyLIwLqyxlYiaodarcP_Iqmr5BHPuszqu2CIvoHLQaN7eeqyDldlrLcho5Isfm8QHdt9G3owOc669B0Gqe73_3igoDnvRxqeKwTMiZkahktZFJYDUNtEyimlXa1gziTjWL0E3RPLGRQms-9C3lKBOs1tJoiv1-gMkIjYx6BSb3mu3O6WvK3zzABP2d2Iu53y1yHvmUVXvXlwr5xBE0zw5_bqOOcNpR9q__Uon_KIdM47U-_s_fag5mCzub7OYLYx4mzGABpk-KSIJPcNHsuN29599_zlP0P4grxmiyC1ySLkG5Gqf9xx3ycJWMST8dyp5Gf6VBkoHGez11RdwLjkhqydBtWWSHJhuLcPEuL_UZKgMc0xIQqyNsgeKQJS4_a00yU8PeY8VpPbE0XIYtnGBxkycREZnzRZlwKAiHgnAoCIfCMrASAlHYQbl9I1DNvd1wreRBFKJoJF5hWHn78SZMIyXix1H7eBVmMjqzM5drUBkP78w6TKn7cW803ChAJ_DrvXl5AZ2NQxA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=EP1281%E2%80%85Total+parietal+peritonectomy%3A+what+morbidity%3F+and+which+sites+of+recurrence%3F&rft.jtitle=International+journal+of+gynecological+cancer&rft.au=Hudry%2C+D.&rft.au=Berthet%2C+A.&rft.au=Saadeh%2C+R.&rft.au=Le+Deley%2C+M.C.&rft.date=2019-11-01&rft.pub=Elsevier+Inc&rft.issn=1048-891X&rft.volume=29&rft.spage=A646&rft.epage=A646&rft_id=info:doi/10.1136%2Fijgc-2019-ESGO.1287&rft.externalDocID=S1048891X24142557 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1048-891X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1048-891X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1048-891X&client=summon |